dr. brufsky discusses the tnacity trial
Published 10 years ago • 61 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
1:41
dr. brufsky discusses the tnacity trial
-
0:35
dr. brufsky discusses bevacizumab benefits in tnbc
-
1:29
dr. brufsky on the colet trial for triple-negative breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
1:22
dr. brufsky on cobimetinib plus paclitaxel in tnbc
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
55:47
5/17/2019 it's a gut feeling: the microbiome in inflammatory disease
-
47:31
iafns: fiber and the gut microbiome with dr. stephen lindemann
-
7:50
medphys - 1.2 - basic physics: atomic structure.
-
1:04
dr. brufsky on the disease-free survival of aromatase inhibitors for breast cancer
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:38
dr. brufsky on the results of a study of trastuzumab and eribulin for her2 mbc
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
1:46
dr. brufsky discusses adjuvant bisphosphonates as a new standard of care
-
1:35
dr. brufsky on cdk 4/6 inihibitors in neoadjuvant breast cancer treatment
-
0:30
dr. brufsky on adjuvant bisphosphonates for patients with breast cancer
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:25
dr. brufsky addresses biosimilar skepticism
-
1:30
dr. brufsky on genomic assays for breast cancer
-
2:12
dr adam brufsky discusses value coordinates of breast cancer care